Clinical trials
Observational Lung Neoplasms trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 20 |
| Recruiting | 12 |
| Completed | 8 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 19 |
| Chung Shan Medical University | 4 |
| Taipei Medical University WanFang Hospital | 3 |
| Academia Sinica, Taiwan | 2 |
| AstraZeneca | 2 |
| Buddhist Tzu Chi General Hospital | 2 |
| Chang Gung Memorial Hospital | 2 |
| Pharus Taiwan, Inc. | 2 |
| Taichung Veterans General Hospital | 2 |
| E-DA Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 44 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Adenocarcinoma of Lung | 2 |
| Breast Neoplasms | 2 |
| Disease | 2 |
| Neoplasms | 2 |
| Tuberculosis | 2 |
| Adenocarcinoma | 1 |
| Anxiety Disorders | 1 |
| Bronchial Neoplasms | 1 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.